[Treatment of neutropenia in HIV infection with hematopoietic growth factors].
Moreno García
M
M
Servicio de Medicina Interna, Hospital Penitenciario, Madrid.
Fernández González
F
F
D017088:AIDS-Related Opportunistic Infections / Q000150:complications; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000009:adverse effects; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D016298:Hematopoietic Cell Growth Factors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000209:etiology; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D016188:Receptors, Granulocyte Colony-Stimulating Factor; D013997:Time Factors; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D016298:Hematopoietic Cell Growth Factors; D016188:Receptors, Granulocyte Colony-Stimulating Factor; D015215:Zidovudine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
Tratamiento de la neutropenia en la infección VIH con factores de crecimiento hematopoyético.